HNSCC clinical samples categorized based on RASAL2-AS1 expression showed correlations with patient survival and clinical stage N (Table S2); however, no significant associations were found with gender, clinical stage M, T stage, clinical stage, or tumor grade. The gene discussed is RASAL2; the disease is head and neck squamous cell carcinoma.